145 related articles for article (PubMed ID: 12748802)
1. [Angioproliferative retinal disease caused by ischemia].
Agostini HT; Hansen LL
Ophthalmologe; 2003 May; 100(5):371-7. PubMed ID: 12748802
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
3. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.
Stone J; Chan-Ling T; Pe'er J; Itin A; Gnessin H; Keshet E
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):290-9. PubMed ID: 8603833
[TBL] [Abstract][Full Text] [Related]
4. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
[TBL] [Abstract][Full Text] [Related]
5. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
[TBL] [Abstract][Full Text] [Related]
7. Transient exposure of rat pups to hyperoxia at normobaric and hyperbaric pressures does not cause retinopathy of prematurity.
Calvert JW; Zhou C; Zhang JH
Exp Neurol; 2004 Sep; 189(1):150-61. PubMed ID: 15296845
[TBL] [Abstract][Full Text] [Related]
8. [Expression of mRNA of vascular endothelial growth factor in a rat model of hyperoxia-induced retinopathy].
Zhang ZH; Jiang L; Qiao LX
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):371-4. PubMed ID: 17706045
[TBL] [Abstract][Full Text] [Related]
9. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
10. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
11. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
12. Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy.
Vessey KA; Wilkinson-Berka JL; Fletcher EL
J Comp Neurol; 2011 Feb; 519(3):506-27. PubMed ID: 21192081
[TBL] [Abstract][Full Text] [Related]
13. Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.
Werdich XQ; McCollum GW; Rajaratnam VS; Penn JS
Exp Eye Res; 2004 Nov; 79(5):623-30. PubMed ID: 15500821
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy.
Sennlaub F; Valamanesh F; Vazquez-Tello A; El-Asrar AM; Checchin D; Brault S; Gobeil F; Beauchamp MH; Mwaikambo B; Courtois Y; Geboes K; Varma DR; Lachapelle P; Ong H; Behar-Cohen F; Chemtob S
Circulation; 2003 Jul; 108(2):198-204. PubMed ID: 12821538
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
[TBL] [Abstract][Full Text] [Related]
16. Novel role of erythropoietin in proliferative diabetic retinopathy.
Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
[TBL] [Abstract][Full Text] [Related]
17. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of retinal neovascularization by soluble EphA2 receptor.
Chen J; Hicks D; Brantley-Sieders D; Cheng N; McCollum GW; Qi-Werdich X; Penn J
Exp Eye Res; 2006 Apr; 82(4):664-73. PubMed ID: 16359662
[TBL] [Abstract][Full Text] [Related]
19. Riluzole inhibits VEGF-induced endothelial cell proliferation in vitro and hyperoxia-induced abnormal vessel formation in vivo.
Yoo MH; Hyun HJ; Koh JY; Yoon YH
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4780-7. PubMed ID: 16303979
[TBL] [Abstract][Full Text] [Related]
20. [Angiogenesis and inhibition of angiogenesis in the eye].
Cursiefen C; Schönherr U
Klin Monbl Augenheilkd; 1997 Jun; 210(6):341-51. PubMed ID: 9333658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
